AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Sanofi pasteur Announces Agreement to License Novel Adjuvant from Eisai Co., Ltd.
LYON, France, Oct. 31 /PRNewswire/ -- Sanofi pasteur, the vaccines business of the sanofi-aventis Group , has entered into an agreement with Eisai Co., Ltd. to license their novel adjuvant, E6020, for use in the development of new vaccines to treat or prevent human illnesses. E6020 is a chemically synthesized adjuvant that will be tested by sanofi pasteur to determine its ability to enhance the immune response to a broad range of vaccines.
Under the terms of the agreement, Eisai will provide a license to sanofi pasteur to incorporate the E6020 adjuvant for use in vaccines throughout all geographical regions. In return Eisai will receive upfront payments, milestone payments, and royalty payments on product sales. Sanofi pasteur will commercialize the adjuvanted vaccines developed in this collaboration. Further financial details of the agreement are not disclosed.
This contract is part of sanofi pasteur's ongoing corporate commitment to protect and improve human health worldwide by providing superior, innovative vaccines for the prevention and treatment of disease.
About sanofi-aventis
The sanofi-aventis Group is the world's third-largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. The sanofi-aventis Group is listed in Paris (EURONEXT: SAN) and in New York .
Sanofi pasteur, the vaccines business of the sanofi-aventis Group, sold nearly a billion doses of vaccine in 2004, making it possible to protect more than 500 million people across the globe, which is about 1.4 million per day. The company offers the broadest range of vaccines, providing protection against 20 bacterial and viral diseases. For more information, please visit: http://www.sanofipasteur.com/
Forward Looking Statements
- Sanofi pasteur Delivers Investigational Pandemic Influenza Vaccine for NIAID...
- Press release article from: PR Newswire March 10, 2005 700+ words
...PRNewswire/ -- Sanofi pasteur (formerly Aventis...separate contract to sanofi pasteur for the establishment...and in New York . Sanofi pasteur, the vaccines business...contains forward-looking statements as defined in the...
- Sanofi Pasteur and Institut Pasteur Team up Against Malaria.
- Press release article from: PR Newswire October 15, 2007 700+ words
...FirstCall/ -- Sanofi Pasteur, the vaccines division...vaccine industry, Sanofi Pasteur offers the broadest...than a century. Sanofi Pasteur is the largest company...fr/. Forward Looking Statements This press release...
- SANOFI PASTEUR PRESENTS RESULTS OF TETRAVALENT DENGUE VACCINE.
- News wire article from: AsiaPulse News November 6, 2007 700+ words
...NYSE: SNY). Sanofi Pasteur, the vaccines division...vaccine industry, Sanofi Pasteur offers the broadest...than a century. Sanofi Pasteur is the largest company...sanofipasteur.us. Forward Looking Statements This press release...
- U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine...
- Press release article from: PR Newswire April 28, 2008 700+ words
...and in New York ; Sanofi Pasteur, the vaccines division...vaccine industry, sanofi pasteur offers the broadest...than a century. Sanofi Pasteur is the largest company...sanofipasteur.us/ Forward Looking Statements This press release...
- Sanofi Pasteur Announces Agreement to License Novel Adjuvant From Eisai Co.,...
- Press release article from: PR Newswire Europe October 31, 2005 700+ words
...SNY). Sanofi pasteur, the vaccines...com Forward Looking Statements This press...forward-looking statements are reasonable...Forward-Looking Statements" in sanofi...Inc. and Sanofi Pasteur Inc. Contact...
- Sanofi Pasteur Receives Seed Virus to Produce New Influenza A(H1N1) Vaccine.
- Press release article from: PR Newswire May 27, 2009 700+ words
...and in New York . Sanofi Pasteur, the vaccines division...vaccine industry, Sanofi Pasteur offers the broadest...than a century. Sanofi Pasteur is the largest company...us/. Forward-Looking Statements This press release...
- Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate...
- Press release article from: PR Newswire November 6, 2007 700+ words
...and in New York . Sanofi Pasteur, the vaccines division...vaccine industry, Sanofi Pasteur offers the broadest...than a century. Sanofi Pasteur is the largest company...sanofipasteur.us/ Forward Looking Statements This press release...
- Sanofi pasteur Supports WHO Initiative for the Establishment of an H5N1 Vaccine...
- Press release article from: PR Newswire June 13, 2007 700+ words
...and in New York . Sanofi pasteur, the vaccines division...vaccine industry, sanofi pasteur offers the broadest...than a century. Sanofi pasteur is the largest company...sanofipasteur.us/ Forward Looking Statements This press release...